The role of peri-operative chemotherapy for resectable colorectal liver metastasis: what does the evidence support?
作者信息
Pawlik Timothy M, Cosgrove David
机构信息
Department of Surgery, The Johns Hopkins University School of Medicine, Harvey 611, 600N Wolfe Street, Baltimore, MD 21287, USA.
出版信息
J Gastrointest Surg. 2011 Mar;15(3):410-5. doi: 10.1007/s11605-011-1423-z. Epub 2011 Jan 21.
Abstract
摘要
相似文献
1
The role of peri-operative chemotherapy for resectable colorectal liver metastasis: what does the evidence support?
J Gastrointest Surg. 2011 Mar;15(3):410-5. doi: 10.1007/s11605-011-1423-z. Epub 2011 Jan 21.
2
What is the standard chemotherapy for colorectal cancer patients with resectable liver metastases?
Nat Clin Pract Oncol. 2009 Jan;6(1):14-6. doi: 10.1038/ncponc1274. Epub 2008 Nov 11.
3
Resectable colorectal liver metastases: optimal sequencing of chemotherapy.
J Gastrointest Cancer. 2012 Sep;43(3):496-8. doi: 10.1007/s12029-011-9272-2.
4
Time to halt perioperative chemotherapy for resectable colorectal liver metastasis?
Br J Surg. 2022 Feb 24;109(3):242-243. doi: 10.1093/bjs/znab425.
5
Peri-operative chemotherapy for patients with resectable colorectal hepatic metastasis: A meta-analysis.
Eur J Surg Oncol. 2015 Sep;41(9):1197-203. doi: 10.1016/j.ejso.2015.05.020. Epub 2015 Jun 11.
6
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.
Eur J Cancer. 2011 Oct;47(15):2291-8. doi: 10.1016/j.ejca.2011.05.014. Epub 2011 Jun 7.
7
Multicentre study of perioperative adjuvant chemotherapy for resectable colorectal liver metastases.
BJS Open. 2019 May 14;3(5):678-686. doi: 10.1002/bjs5.50174. eCollection 2019 Oct.
8
Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
J Surg Oncol. 2012 Jan;105(1):55-9. doi: 10.1002/jso.22044. Epub 2011 Aug 12.
9
Improved first-line chemotherapy: a better chance for surgery?
Lancet Oncol. 2010 Jan;11(1):4-5. doi: 10.1016/S1470-2045(09)70345-6. Epub 2009 Nov 26.
10
[Combination of neoadjuvant chemotherapy, cryotherapy and surgery in the treatment of unresectable colorectal liver metastases. Long-term results].
Tumori. 2003 Jul-Aug;89(4 Suppl):107-8.
引用本文的文献
1
Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).
Ann Gastroenterol. 2016 Oct-Dec;29(4):390-416. doi: 10.20524/aog.2016.0050. Epub 2016 Jun 3.
2
Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis.
J Gastrointest Surg. 2015 Sep;19(9):1668-75. doi: 10.1007/s11605-015-2873-5. Epub 2015 Jun 16.
3
Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.
PLoS One. 2014 Jan 21;9(1):e86543. doi: 10.1371/journal.pone.0086543. eCollection 2014.
4
HER2-positive gastric cancer.
Gastric Cancer. 2014 Jan;17(1):1-12. doi: 10.1007/s10120-013-0252-z. Epub 2013 Apr 7.
5
SSAT/AHPBA Joint Symposium: Today's approaches to colorectal cancer (CRC) liver metastases.
J Gastrointest Surg. 2011 Mar;15(3):404-5. doi: 10.1007/s11605-011-1425-x. Epub 2011 Feb 1.
本文引用的文献
1
Role of adjuvant therapy after resection of colorectal cancer liver metastases.
J Clin Oncol. 2010 May 1;28(13):2300-9. doi: 10.1200/JCO.2009.26.9340. Epub 2010 Apr 5.
2
Resection margin and recurrence-free survival after liver resection of colorectal metastases.
Ann Surg Oncol. 2010 May;17(5):1324-9. doi: 10.1245/s10434-009-0770-4. Epub 2009 Oct 22.
3
Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis.
J Gastrointest Surg. 2009 Dec;13(12):2141-51. doi: 10.1007/s11605-009-1050-0. Epub 2009 Oct 1.
4
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients.
Ann Surg. 2009 Sep;250(3):440-8. doi: 10.1097/SLA.0b013e3181b4539b.
5
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer.
Ann Oncol. 2009 Dec;20(12):1964-70. doi: 10.1093/annonc/mdp236. Epub 2009 Jun 30.
6
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.
J Clin Oncol. 2009 Jul 1;27(19):3109-16. doi: 10.1200/JCO.2008.20.6771. Epub 2009 May 18.
7
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.
Ann Oncol. 2009 Nov;20(11):1842-7. doi: 10.1093/annonc/mdp233. Epub 2009 Apr 30.
8
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.
N Engl J Med. 2009 Apr 2;360(14):1408-17. doi: 10.1056/NEJMoa0805019.
9
Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
Ann Surg Oncol. 2009 Jul;16(7):1844-51. doi: 10.1245/s10434-009-0348-1. Epub 2009 Feb 18.
10
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).
Ann Oncol. 2009 Apr;20(4):674-80. doi: 10.1093/annonc/mdn680. Epub 2009 Jan 29.
Zotero 插件